MUMBAI (Reuters) - Generics drugmaker Alkem Laboratories raised 13.5 billion rupees ($201.88 million) in its initial public offering after pricing shares at 1,050 rupees each, according to its prospectus.
Pricing was at the top end of its 1,020-1,050 rupee price band.
Alkem is expected to list on exchanges on or before Dec. 29, according to a source familiar with the listing. The IPO was subscribed 44.3 times.
($1 = 66.8700 Indian rupees)
Reporting by Karen Rebelo in Mumbai; Editing by Subhranshu Sahu
Our Standards: The Thomson Reuters Trust Principles.